November 26, 2025 at 05:49PM ITVISMA

For the treatment of spinal muscular atrophy (SMA) in adult and pediatric patients 2 years of age and older with confirmed mutation in survival motor neuron 1 (SMN1) gene.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/jTLAdeR